Prophylactic Anticoagulant Treatment Might Have an Anti-inflammatory Effect and Reduce Mortality Rates in Hospitalized COVID-19 Patients?

OBJECTIVES: COVID-19 associated coagulopathy and prophylactic anticoagulant therapy (PAT) are ongoing topics globally. Using PAT for anti-inflammatory effect may prevent thromboembolic events (TEEs). The objective of this study was to determine the anti-inflammatory effects of PAT in hospitalized CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkan, Sevil, Şener, Alper, Doğan, Ebru, Yüksel, Cihan, Yüksel, Buse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OMJ 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241148/
https://www.ncbi.nlm.nih.gov/pubmed/35915761
http://dx.doi.org/10.5001/omj.2022.77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241148/
https://www.ncbi.nlm.nih.gov/pubmed/35915761
http://dx.doi.org/10.5001/omj.2022.77

Ejemplares similares